All peptides

Sermorelin vs Tesamorelin

Updated · Educational, not medical advice

The short answer

Both are growth hormone-releasing hormone (GHRH) analogs that prompt the pituitary to release your own growth hormone. The key difference is evidence: tesamorelin is FDA-approved (Egrifta) to reduce abdominal fat in HIV-associated lipodystrophy, based on randomized trials; sermorelin's branded product (Geref) was withdrawn for commercial reasons and adult wellness evidence is limited.

Side by side

What it isSermorelin:Sermorelin mimics GHRH, the hypothalamic signal that tells the pituitary to release growth hormone, so growth hormone levels follow the body's own rhythm rather than being replaced directly.Tesamorelin:Tesamorelin is a modified form of growth hormone-releasing hormone given by daily injection.
Human evidenceSermorelin:It was studied and approved decades ago for growth hormone deficiency in children. Evidence in adults for energy, sleep, body composition or aging is limited.Tesamorelin:Randomized controlled trials in people with HIV-associated lipodystrophy showed reductions in visceral (abdominal) fat, which led to FDA approval. Evidence outside that population is more limited.
FDA statusSermorelin:The branded product (Geref) was FDA-approved and later withdrawn for commercial reasons. Today it is prescribed as a compounded preparation, which is not FDA-approved.Tesamorelin:The active ingredient is FDA-approved (Egrifta) for a specific use. A compounded preparation is not FDA-approved and is not the branded product.
Side effectsSermorelin:Reported effects include injection-site reactions, flushing and headache. Clinicians usually check that there is no history of cancer or uncontrolled pituitary conditions before prescribing.Tesamorelin:Labeled side effects include joint pain, injection-site reactions, swelling in the arms or legs and muscle pain. It can raise blood sugar, so clinicians usually check labs.
At PacificRxSermorelin:From $109/month with clinician reviewTesamorelin:From $249/month with clinician review

Questions

What is the difference between Sermorelin and Tesamorelin?

Both are growth hormone-releasing hormone (GHRH) analogs that prompt the pituitary to release your own growth hormone. The key difference is evidence: tesamorelin is FDA-approved (Egrifta) to reduce abdominal fat in HIV-associated lipodystrophy, based on randomized trials; sermorelin's branded product (Geref) was withdrawn for commercial reasons and adult wellness evidence is limited.

Can you take Sermorelin and Tesamorelin together?

They act on the same receptor, so they are generally prescribed as alternatives rather than together.

Do I need a prescription for Sermorelin or Tesamorelin?

Yes. Both should be prescribed by a licensed clinician and prepared by a licensed pharmacy. Avoid products sold as "research use only".

Sources

More peptide comparisons